主要財務データMajor Financial Data〈ファーマシー事業〉期末店舗数Dispensing pharmacy business:Number of stores at end of the year〈ファーマシー事業〉処方箋枚数／処方箋単価Dispensing pharmacy business:Prescription volume /Average prescription price（円 ¥ ）（千枚 Thousands ）1,200 -25,000 -- 13,000- 12,00020,000 -900 -- 11,00015,000 -600 -- 10,00010,000 - 9,000300 5,000 016/417/418/419/4020/4期末店舗数 Number of stores at end of the year〈リテール事業〉期末店舗数Cosmetic and drug store business:Number of stores at end of the year- 8,00016/417/418/419/47,00020/4処方箋枚数 Prescription volume（ 左軸 left scale）処方箋単価 Average prescription price（ 右軸 right scale）〈リテール事業〉客数／客単価Cosmetic and drug store business:Number of customers /Average customer spend（円 ¥ ）（千人 Thousands ）70 -10,000 -- 3,00060 - 2,5008,000 -50 -- 2,00040 -6,000 - 1,50030 4,000 -20 -- 1,0002,000 -10 016/417/418/419/4020/4期末店舗数 Number of stores at end of the year- 50016/417/4Prescription volume (thousands)処方箋単価（円）Average prescription price (yen)〈リテール事業 Cosmetic and drug store business〉期末店舗数Number of stores at end of the year期末売場面積（㎡）Total sales floor at end of the year (㎡ )客数（千人）Number of customers (thousands)客単価（円）Average customer spend (yen)処方箋枚数（千枚）

319/4020/4客数 Number of customers（ 左軸 left scale）客単価 Average customer spend（ 右軸 right scale）連結〈ファーマシー事業 Dispensing pharmacy business〉期末店舗数Number of stores at end of the year18/4Consolidated15/416/417/418/419/420/475414,36511,53888117,05012,1491,06619,71411,0321,02921,22211,0511,13222,56610,6871,08822,94711,304

5620,8858,5022,094

5220,3678,9502,333

5220,6308,9222,396

4819,2909,3632,576

5421,1439,6422,615

6326,2059,9412,492

連結財務諸表Consolidated Financial Statements連結貸借対照表Consolidated Balance Sheet会計年度末At fiscal year-end（資産の部）Assets:（百万円¥ Millions ）18/419/420/4Current assets:94,55785,44687,802現金及び預金Cash on hand and in banks63,77948,09146,321受取手形及び売掛金Notes and accounts receivable10,46612,77113,653たな卸資産Inventories9,58012,89815,322短期貸付金Short-term loans641236208未収入金Other accounts receivable7,7518,4388,997その他Other current assets2,4703,0123,299貸倒引当金Allowance for doubtful accounts（131）Fixed assets:88,718103,515105,632Property, plant and equipment:27,85330,18630,874建物及び構築物（純額）Buildings and structures, net14,93416,35216,609土地Land10,04110,39410,960建設仮勘定Construction in progress118283143流動資産固定資産有形固定資産（2）（1）Other property, plant and equipment, net2,7593,1553,161無形固定資産Intangible fixed assets40,13247,57744,916投資その他の資産資産合計Investments and other assetsTotal assets20,732183,38025,751189,02129,841193,451（負債の部）Liabilities:Current liabilities:69,95073,74474,700買掛金Accounts payable38,72844,79447,187短期借入金Short-term debt6,7175,5713,642未払法人税等Accrued income taxes4,9473,2613,356その他（純額）流動負債預り金Deposits received12,67512,73713,094賞与引当金Allowance for bonuses to employees1,9112,1392,338役員賞与引当金Allowance for bonuses to directors161716ポイント引当金Reserve for reward obligations420450463その他Other current liabilitiesLong-term liabilities:4,53216,6964,77211,3554,6007,747固定負債長期借入金Long-term debt11,5115,9852,432リース債務Lease obligations632401154退職給付に係る負債Net defined benefit liability2,6252,9773,124その他Other long-term liabilities1,9271,9892,035負債合計Total liabilities86,64685,09982,447（純資産の部）Net assets:Shareholders’ equity:96,662103,920111,151資本金Common stock21,89421,89421,894資本剰余金Capital surplus20,50020,50020,500利益剰余金Retained earnings54,26861,52668,758株主資本自己株式その他の包括利益累計額Treasury stockAccumulated other comprehensive income (loss)（1）34（2）（2）（65）（236）（59）（159）その他有価証券評価差額金Unrealized holding gains on securities84退職給付に係る調整累計額Remeasurements of defined benefit plansNon-controlling interests（50）非支配株主持分純資産合計Total net assets96,733103,922111,003負債純資産合計Total liabilities and net assets183,380189,021193,45136（6）67（77）88

4

連結財務諸表Consolidated Financial Statements連結損益計算書Consolidated Statement of Income会計年度Fiscal years endedNet salesCost of sales売上総利益Gross profit販売費及び一般管理費Selling, general and administrative expenses営業利益Operating income営業外収益Non-operating income営業外費用Non-operating expenses経常利益Ordinary income特別利益Extraordinary income特別損失Extraordinary losses税金等調整前当期純利益Income before income taxes法人税、住民税及び事業税Income taxes-current法人税等調整額Income taxes-deferred当期純利益Profit非支配株主に帰属する当期純利益 Profit attributable to non-controlling interests親会社株主に帰属する当期純利益 Profit attributable to owners of parent売上高売上原価連結キャッシュ・フロー計算書Fiscal years ended営業活動によるキャッシュ・フローCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesNet increase in cash and cash equivalentsCash and cash equivalents at beginningof the yearCash and cash equivalents at end of the year財務活動によるキャッシュ・フロー現金及び現金同等物の増加額現金及び現金同等物の期首残高現金及び現金同等物の期末残高

518/4268,385220,39247,99328,37019,6221,11761020,1292552,53217,8527,863（540）10,530（37）10,56719/4292,615245,75346,86130,79316,0681,22647216,8228351,72715,9306,648
819,201
219,179（百万円18/421,656（5,281）

17,62333,99819/414,788¥ Millions ）20/4275,596230,23345,36329,29516,0671,06149016,6371,0612,07415,6246,794（230）9,060
309,029Consolidated Statement of Cash Flows会計年度投資活動によるキャッシュ・フロー（百万円¥ Millions ）20/417,747（19,985）（11,474）（15,878）（1,564）（10,681）（7,837）

29,23463,23347,49563,23347,49545,931

Segment Information◆セグメント情報ファーマシー事業 Dispensing pharmacy business16/417/418/419/420/4売上高Sales211,009221,801238,645245,003263,750Segment income19,21919,11022,66818,33120,850減価償却費Depreciation and amortization2,0702,2992,2292,5382,67620,88421,38324,11725,21024,701(459)(866)657972262262357334315391セグメント利益（損失） Segment income (loss)減価償却費Depreciation and amortization◆設備投資／減価償却費Capital Investment / Depreciation and Amortization設備投資減価償却費Capital investmentDepreciation and amortization注：¥ Millions ）セグメント利益Cosmetic and drug store business売上高Salesリテール事業（百万円16/417/411,2093,25918/44,7863,6875,3113,596¥ Millions ）（百万円19/420/49,9193,90310,5364,087設備投資=有形及び無形固定資産+敷金・保証金Note: Capital investment = Property, plant and equipment + Intangible fixed assets + Deposits and guaranteesNumber of Stores by Region◆地域別店舗数（ 2020年 4 月期末現在）（ At end of the fiscal year ended April 30, 2020）北海道東北 関東・甲信越 北陸・東海 近畿 中国・四国 九州・沖縄Hokkaido Tohoku Kanto/Koshinetsu Hokuriku/Tokai Kinki Chugoku/Sikoku Kyusyu/Okinawaファーマシー事業リテール事業Dispensing pharmacy businessCosmetic and drug store business成長の推移101181692452361072126391142
1History of Growth当社は診療報酬及び薬価改定による影響を吸収して、成長・拡大しています。今後も新規出店及びM&Aを積極的に実施し、規模拡大政策を継続していきます。
The AIN HOLDINGS Group has grown and expanded while dealing with the impact of revisions to medical fee and drugprices. The opening of new stores and M&A has been actively implemented to continue the scale expansion policy.
11/4期FY4/1112/4期FY4/1213/4期FY4/13Revisions15/4期FY4/1516/4期FY4/1617/4期FY4/1718/4期FY4/18調剤報酬改定調剤報酬改定調剤報酬改定調剤報酬改定Revision ratio ondispensing feesRevision ratio ondispensing feesRevision ratio ondispensing feesRevision ratio ondispensing fees+ 0.46%医療費改定14/4期FY4/14+ 0.22%+ 0.17%薬価改定薬価改定薬価改定Revision ratio ondrug pricesRevision ratio ondrug pricesRevision ratio ondrug pricesRevision ratio ondrug prices-2.65%-7.77%20/4期FY4/20調剤報酬改定+ 0.19%薬価改定-6.0%19/4期FY4/19+ 0.12% ※1+ 0.16% ※2Revision ratio ondispensing fees薬価改定-7.48%-2.4% ※1-4.38% ※2Revision ratio ondrug prices調剤事業会社の 6社
9社11社13社15社23社38社
7社12社
2社M&A （35店舗） （28店舗） （38店舗） （26店舗） （119店舗） （110店舗） （182店舗） （11店舗） （134店舗） （6店舗）M&As ofdispensingpharmacycompanies6 companies(35 stores)9 companies(28 stores)11 companies(38 stores)13 companies(26 stores)15 companies(119 stores)23 companies(110 stores)38 companies(182 stores)7 companies(11 stores)12 companies(134 stores)2 companies(6 stores)※1 消費増税に伴い2019年10月に実施 which are conducted in October 2019 due to the consumption tax rate increased※2 2020年4月に実施 which are conducted in April 2020（百万円 ¥ Millions ）20,00015,000200,000150,00010,000100,0005,00050,000
011/412/413/4連結売上高 Consolidated net sales（ 左軸 left scale）14/415/416/417/418/419/420/4

0連結営業利益連結売上高Consolidated net sales250,000Consolidated operating income（百万円 ¥ Millions ）300,000連結営業利益 Consolidated operating income（右軸 right scale）6